These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


427 related items for PubMed ID: 15124255

  • 21. Antigenicity study of muroctasin.
    Yamaguchi F, Hattori H, Wagai N, Tsukada W.
    Arzneimittelforschung; 1988 Jul; 38(7A):1034-7. PubMed ID: 3190797
    [Abstract] [Full Text] [Related]

  • 22. Antigenicity study of the new cognition-enhancing agent nefiracetam.
    Wagai N, Yamaguchi F, Hasegawa T, Takayama S.
    Arzneimittelforschung; 1994 Feb; 44(2A):247-50. PubMed ID: 8018098
    [Abstract] [Full Text] [Related]

  • 23. Prospective, multi-centre, randomised evaluation of the safety and efficacy of five dosing regimens of viscosupplementation with hylan G-F 20 in patients with symptomatic tibio-femoral osteoarthritis: a pilot study.
    Conrozier T, Jerosch J, Beks P, Kemper F, Euller-Ziegler L, Bailleul F, Chevalier X.
    Arch Orthop Trauma Surg; 2009 Mar; 129(3):417-23. PubMed ID: 18365224
    [Abstract] [Full Text] [Related]

  • 24. The use of hylan G-F 20 after knee arthroscopy in an active patient population with knee osteoarthritis.
    Zietz PM, Selesnick H.
    Arthroscopy; 2008 Apr; 24(4):416-22. PubMed ID: 18375273
    [Abstract] [Full Text] [Related]

  • 25. IgE antibody production in guinea pigs treated with cyclophosphamide.
    Graziano F, Haley C, Gundersen L, Askenase PW.
    J Immunol; 1981 Sep; 127(3):1067-70. PubMed ID: 6790610
    [Abstract] [Full Text] [Related]

  • 26. Immunological and allergenic responses induced by latex fractions of Calotropis procera (Ait.) R.Br.
    Ramos MV, Aguiar VC, Melo VM, Mesquita RO, Silvestre PP, Oliveira JS, Oliveira RS, Macedo NM, Alencar NM.
    J Ethnopharmacol; 2007 Apr 20; 111(1):115-22. PubMed ID: 17141437
    [Abstract] [Full Text] [Related]

  • 27. Antigenicity studies on catena-(S)-[mu-[N alpha-(3-aminopropionyl)histidinato(2-)-N1,N2,O:N tau]-zinc].
    Shibata K, Matsuda K, Wada H, Aruga F, Yamada Y.
    Arzneimittelforschung; 1991 Oct 20; 41(10):1048-52. PubMed ID: 1799382
    [Abstract] [Full Text] [Related]

  • 28. A newly described activity of guinea pig IgG1 antibodies: transfer of cutaneous basophil reactions.
    Haynes JD, Rosenstein RW, Askenase PW.
    J Immunol; 1978 Mar 20; 120(3):886-94. PubMed ID: 344798
    [Abstract] [Full Text] [Related]

  • 29. The effect of anti-eosinophil serum on skin histamine replenishment following passive cutaneous anaphylaxis in the guinea-pig.
    Jones DG, Kay AB.
    Immunology; 1976 Sep 20; 31(3):333-6. PubMed ID: 68922
    [Abstract] [Full Text] [Related]

  • 30. A guinea pig model of hypersensitivity to allergenic fractions of natural rubber latex.
    Aamir R, Safadi GS, Mandelik J, Cornish K, Melton AL, Pien LC, Wagner WO, Battisto JR.
    Int Arch Allergy Immunol; 1996 Jun 20; 110(2):187-94. PubMed ID: 8645998
    [Abstract] [Full Text] [Related]

  • 31. Intradermal and oral immunization with recombinant Mycobacterium bovis BCG expressing the simian immunodeficiency virus Gag protein induces long-lasting, antigen-specific immune responses in guinea pigs.
    Kawahara M, Matsuo K, Honda M.
    Clin Immunol; 2006 Apr 20; 119(1):67-78. PubMed ID: 16386958
    [Abstract] [Full Text] [Related]

  • 32. Native hyaluronan produces less hypersensitivity than cross-linked hyaluronan.
    Goomer RS, Leslie K, Maris T, Amiel D.
    Clin Orthop Relat Res; 2005 May 20; (434):239-45. PubMed ID: 15864059
    [Abstract] [Full Text] [Related]

  • 33. Identification of IgG-antibodies in subjects with hay fever before and after specific hyposensitizing treatment.
    Patriarca G, Venuti A, Bonini W.
    Ann Allergy; 1973 May 20; 31(5):223-7. PubMed ID: 4697679
    [No Abstract] [Full Text] [Related]

  • 34. IgG1 antibody-dependent mediator release after passive systemic sensitization of basophils arriving at cutaneous basophil hypersensitivity reactions.
    Mitchell EB, Brown SJ, Askenase PW.
    J Immunol; 1982 Oct 20; 129(4):1663-9. PubMed ID: 6180018
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Inflammatory and immunological responses to hyaluronan preparations. Study of a murine biocompatibility model.
    Ottaviani RA, Wooley P, Song Z, Markel DC.
    J Bone Joint Surg Am; 2007 Jan 20; 89(1):148-57. PubMed ID: 17200322
    [Abstract] [Full Text] [Related]

  • 37. No conclusive evidence that histologically found granulomas and acute local reactions following hylan G-F 20 injections are related or have clinical significance.
    Waddell DD, Beyer A, Thompson TL, Morawiak J, Elkins C, Rosenberg A, Spitzer A.
    J Knee Surg; 2014 Apr 20; 27(2):99-104. PubMed ID: 23873318
    [Abstract] [Full Text] [Related]

  • 38. Hylan G-F 20 tolerability with repeat treatment in a large orthopedic practice: a retrospective review.
    Waddell DD, Bricker DC.
    J Surg Orthop Adv; 2006 Apr 20; 15(1):53-9. PubMed ID: 16603113
    [Abstract] [Full Text] [Related]

  • 39. [Omparative study on allergen assessment animal models in Brown Norway rat and guinea pig].
    Liu T, Liang A, Yi Y, Li C, Zhao Y, Hao R, Cao C.
    Zhongguo Zhong Yao Za Zhi; 2009 Feb 20; 34(4):472-5. PubMed ID: 19459315
    [Abstract] [Full Text] [Related]

  • 40. [[Antigenicity study of 6-amidino-2-naphthyl 4(-)[(4,5-dihydro-1H-imidazol-2-yl)amino] benzoate dimethanesulfonate (FUT-187) in guinea pigs and mice].
    Kuramoto S, Oda M, Terazawa K, Terabayashi M, Otani K, Shimamura K, Ouchida A.
    J Toxicol Sci; 1992 Dec 20; 17 Suppl 4():287-301. PubMed ID: 1296027
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 22.